CLINICAL_TRIALS
trial_result
· 2017-10-17
Clinical Trial Update: Emtricitabine/Tenofovir Alafenamide as Salvage ART [Phase 2]
Summary
A Phase 2 trial of emtricitabine/tenofovir alafenamide as salvage ART in HIV was terminated, with results posted in October 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV | Phase 2 | Status: TERMINATED | Results posted: 2017-10-17